Search clinical trials for: hydroxyethyl starch (HES 130/0.6)

Total 404 results

Konkuk University Medical Center

Completed

Acute Normovolemic Hemodilution on ROTEM in Cardiac Surgery

Mitral Regurgitation | Tricuspid Regurgitation | Mitral Stenosis

Korea, Republic of
Konkuk University Medical Center

Completed

Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery

Mitral Regurgitation | Tricuspid Regurgitation | Mitral Stenosis

Korea, Republic of
Fresenius Kabi

Terminated

Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

Intraoperative Complications

China
Sifa University

Unknown

Colloid Preload Versus Colloid Coload During Cesarean Deliveries

Hypotension | Anesthesia; Adverse Effect, Spinal and Epidural

Turkey
University of Debrecen

Completed

The Mortality and Changes in Quality of Life of Patients Suffering From SAH With Different Hydration Strategies

Subarachnoid Hemorrhage

Hungary
China International Neuroscience Institution

Completed

Effects of Crystal Solution and Colloid Solution on Mother and Fetus

Cesarean Section | Spinal Anesthesia | Parturition

China
London Health Sciences Centre

Terminated

Starch or Saline After Cardiac Surgery (SSACS)

Coronary Artery Bypass Surgery

Canada
Queen Fabiola Children's University Hospital

Completed

Colloids in Pediatric Cardiac Surgery: Comparison Between a Balanced and a Non-balanced Colloid (COLCHIRCARD)

Cardiac Surgery | Cardiopulmonary Bypass

Belgium
Fresenius Kabi Japan

Completed

Trial of 6% HES130/0.4

Hemorrhage | Hypovolemia

Japan
Yuanyuan Zhang
Tianjin First Central Hospital; Tianjin Union Medical Center

Completed

Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery

Total Fluid Volume Increased

China
Fresenius Kabi

Completed

Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery

Postoperative Complications

China
Fresenius Kabi Japan

Completed

Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective Surgery

Plasma Volume Substitution (Hypovolemia) Including Massive Hemorrhage

Japan
Hospices Civils de Lyon

Completed

Priming of Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 or Sodium Chloride 0.9% : Pilot Study in Adult Elective Conventional Cardiac Surgery (OPTIMUS-PRIME)

Cardiac Surgery | Extracorporeal Circulation

France
Asan Medical Center

Completed

Comparison of Hemodynamic Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy

Pancreaticoduodenectomy

Korea, Republic of
Yonsei University

Completed

A Comparison Between 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 in Priming Solution for Cardiopulmonary Bypass and Post-bypass Maintenance Fluid in High-risk Patients

Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Korea, Republic of
Sangart

Completed

Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

Vascular Disease | Critical Lower Limb Ischemia

Sweden
Xijing Hospital

Unknown

Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection as Adjunctive Therapy in Subjects With Internal Carotid Artery Hypoperfusion

Brain Hypoperfusion

China
Hopital Foch

Terminated

Closed-loop Fluid Administration System: Pilot Study to Evaluate Feasibility

Anesthesia

France
General Hospital of Ningxia Medical University

Recruiting

6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension

Adverse Effect

China
Yonsei University

Completed

Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

Mitral Valvular Heart Disease
Sangart

Completed

Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty

Ischemia | Hypotension

Netherlands, Belgium, Czech Republic, Sweden, Poland, United Kingdom
Sangart

Completed

Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty

Ischemia | Hypotension

Netherlands, Belgium, Sweden, Czech Republic, Poland
Nanjing Medical University

Completed

Fluid Management for Cesarean Section III (FMCS-III)

Cesarean Section

China
Nanjing Medical University

Completed

Perineuraxial Anesthesia Fluid Management and Infant Neurobehaviors (PAFUMIN)

Cesarean Section

China
Nanjing Medical University

Completed

Fluid Volume-hypotension Association in Cesarean Under Neuraxial Anesthesia (VOHOCUNA)

Cesarean Section

China
The Cleveland Clinic

Completed

Endothelial Function After Cardiac Surgery

Endothelial Dysfunction

United States
Nanjing Medical University
Nanjing Maternity and Child Health Care Hospital

Completed

Fluid Management for Cesarean Section II (FMCS-II)

Cesarean Section

China
Yonsei University

Completed

Respirophasic Carotid Artery Peak Velocity Variation as a Predictor of Fluid Responsiveness in Patients With Coronary Disease

Coronary Artery Occlusive Disease

Korea, Republic of
Yonsei University

Completed

The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery

Coronary Artery Occlusive Disease

Korea, Republic of
University Hospital, Strasbourg, France

Completed

HES Patch Versus Blood Patch

Intracranial Hypotension

France
Fresenius Kabi
B. Braun Melsungen AG; European Society of Anaesthesiology and Intensive Care

Completed

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery (PHOENICS)

Hypovolaemia Due to Acute Blood Loss

Spain, France, Netherlands, Germany, Poland, Belgium, Czechia, Croatia, Austria, Romania
University Hospital, Caen

Completed

Observational Study of Oxygen Delivery During a Fractional Fluid Expansion (OR)

Hypovolemia | Cardiac Output, Low | Impaired Oxygen Delivery

France
Regional Hospital Holstebro

Terminated

Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy (VONE)

Kidney Cancer

Denmark
Fresenius Kabi

Completed

Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis (CRYSTMAS)

Sepsis

France, Germany
Regional Hospital Holstebro

Completed

Hydroxyethyl Starch and Renal Function After Radical Prostatectomy (VORA)

Prostate Cancer

Denmark
Anders Perner
Rigshospitalet, Denmark; University of Copenhagen; B. Braun Melsungen AG; Copenhagen...

Completed

Scandinavian Starch for Severe Sepsis/Septic Shock Trial (6S)

Septic Shock | Severe Sepsis

Denmark, Norway, Finland, Iceland
Fresenius Kabi

Completed

VolulyteTM in Cardiac Surgery

Heart; Dysfunction Postoperative, Cardiac Surgery

Canada
Regional Hospital Holstebro

Completed

Hydroxyethyl Starch and Renal Function After Hip Replacement Surgery (VOHO)

Osteoarthritis

Denmark
University Hospital Muenster
Fresenius Kabi

Terminated

Perioperative Colloid vs Crystalloid in Patients Undergoing Colorectal Surgery (KoKris)

Surgery, Colorectal

Germany
Xijing Hospital
Ningbo No.2 Hospital

Recruiting

Colloid Infusion for Optimal Outcomes In Non-cardiac Surgery (COIN Trial) (COIN)

Postoperative Complications

China
The George Institute
University of Sydney; Fresenius Kabi; Australian and New Zealand Intensive Care...

Completed

Crystalloid Versus Hydroxyethyl Starch Trials (CHEST)

Intensive Care

Australia
Meshalkin Research Institute of Pathology of Circulation

Completed

The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients. (ESHHS)

Coronary Artery Disease | Edema

Russian Federation
Fresenius Kabi
B. Braun Melsungen AG; European Society of Anaesthesiology and Intensive Care

Completed

Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients (TETHYS)

Hypovolemia Due to Acute Blood Loss

Germany, Spain, France, Czechia, South Africa, Belgium, Netherlands
University Hospital, Clermont-Ferrand

Completed

Hemostasis Evolution During Fluid Loading in Abdominal Surgery. Effects of Fluid Choice: Saline Versus Hydroxyethyl Starch (HAEMO Study) (HAEMO)

Postoperative Mortality | Postoperative Morbidity | Hemostasis Change

France
St. Boniface Hospital
University of Manitoba

Unknown

This Study Will Compare the Effect of Starch Containing to Non-Starch Containing Intravenous Fluid on Blood Loss During Coronary Artery Bypass Graft Surgery

Bloodloss
Chung-Ang University Hosptial, Chung-Ang University...

Unknown

Study of Stroke Volume Variation and Pleth Variability Index as Predictors of Fluid Responsiveness

Thyroidectomy | Fluid Responsiveness

Korea, Republic of
University of Sao Paulo

Completed

Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty

Hip Replacement Arthroplasty

Brazil
University Hospital, Basel, Switzerland
Fresenius AG

Completed

BaSES Trial: Basel Starch Evaluation in Sepsis (BaSES)

Sepsis | Septic Shock | Severe Sepsis

Switzerland
The Cleveland Clinic
Fresenius Kabi

Completed

Use of 6% Hydroxyethylstarch (130/0.4) in Cardiac Surgical Patients (SHARP)

Postoperative Kidney Injury

United States
Seoul National University Hospital

Completed

The Effect of the Hydroxyethyl Starch on Kidney Injury in Pediatric Cardiac Surgery

Acute Kidney Injury

Korea, Republic of

Search clinical trials for: hydroxyethyl starch (HES 130/0.6)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations